Automated Imaging and Analysis for the Quantification of Fluorescently Labeled Macropinosomes
August 24th, 2021
Automated assays using multi-well microplates are advantageous approaches for identifying pathway regulators by allowing the assessment of a multitude of conditions in a single experiment. Here, we have adapted the well-established macropinosome imaging and quantification protocol to a 96-well microplate format and provide a comprehensive outline for automation using a multi-mode plate reader.
Overview
This study presents an automated protocol for quantifying macropinocytosis, a crucial endocytic pathway involved in cellular processes such as cancer metabolism. The method adapts a macropinosome imaging protocol to a 96-well microplate format, enhancing the ability to assess multiple experimental conditions simultaneously.
Key Study Components
Research Area
- Cell biology
- Endocytosis mechanisms
- Cancer metabolism
Background
- Macropinocytosis plays a significant role in nutrient uptake and signal transduction.
- Understanding this pathway is essential for insights into cancer cell behavior.
- Automation in assays helps improve reproducibility and efficiency in experimental settings.
Methods Used
- Utilization of multi-well microplates for high-throughput analysis
- In vitro cellular systems for testing
- Fluorescent microscopy for imaging and quantification
Main Results
- Successful adaptation of a macropinosome imaging protocol to a 96-well format.
- Enhanced ability to visualize and quantify cellular uptake.
- Demonstration of automation leading to reduced experimental variation.
Conclusions
- This study demonstrates an efficient and automated method for studying macropinocytosis.
- The developed protocol is relevant for advancing research in cell biology and cancer metabolism.
Frequently Asked Questions
Executive Industry Relevance
Automated quantification of fluorescently labeled macropinosomes enables high-throughput, reproducible assessment of macropinocytosis, a pathway implicated in cancer metabolism and immune regulation. This workflow supports robust target validation and mechanistic de-risking at the discovery stage, facilitating confident triage of candidate modulators. Integration of automation and quantitative imaging enhances portfolio decision-making by reducing experimental variability and increasing assay scalability.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables systematic interrogation of macropinocytosis regulators under diverse conditions.
- Supports functional validation of pathway involvement in disease-relevant cellular models.
- Provides quantitative benchmarks for mechanistic de-risking of candidate targets.
- Facilitates comparative analysis of pathway modulation across compound series.
Screening & Assay Development
- Delivers standardized, automated readouts suitable for multi-well screening formats.
- Improves reproducibility and throughput for compound or genetic perturbation studies.
- Generates quantitative macropinocytic index data for reliable hit triage.
- Enables rapid assessment of assay robustness and dynamic range across conditions.
Translational & Preclinical Research
- Aligns in vitro macropinocytosis quantification with disease-relevant cellular phenotypes.
- Supports continuity from discovery through preclinical validation of pathway-targeted interventions.
- Provides a platform for evaluating translational biomarkers of macropinocytic activity.
- Enables risk-adjusted advancement of candidates based on functional pathway engagement.
Pipeline & Workflow Integration
This automated imaging and analysis method fits within the early discovery to lead identification continuum, supporting both hypothesis-driven and screening-based workflows.
- Discovery Biology: Quantitative imaging enables hypothesis testing of macropinocytosis modulation and pathway mapping.
- Screening: Multi-well compatibility and automation support reproducible, scalable assay deployment for compound libraries.
- Analytics: Provides normalized macropinocytic index outputs for cross-condition and cross-experiment comparison.
- Translational Research: Facilitates alignment of in vitro findings with disease-relevant cellular phenotypes when supported by model selection.
- Enterprise Reuse: Standardized protocol and automation enable broad adoption across discovery teams and projects.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in pathway engagement and target validation.
- Operational Value: Enhances reproducibility, throughput, and standardization across experiments.
- Strategic Value: Supports informed go/no-go decisions and reduces late-stage biological risk.
- Portfolio Impact: Enables risk-adjusted prioritization of pathway-targeted programs.
Implementation Considerations
- Requires expertise in cell culture, fluorescence imaging, and quantitative analysis.
- Needs access to multi-mode plate readers or automated fluorescence microscopes.
- Demands cross-team standardization of imaging and analysis parameters.
- Adaptable to various adherent cell models and fluorescent cargoes with protocol optimization.
- Potential limitations include sensitivity to imaging settings and requirement for robust background subtraction.
Biopharma FAQs
Chapters in this video
0:05
Introduction
0:44
Preparation of Cells
2:40
Macropinosome Labeling
6:47
Automated Macropinosome Imaging
7:46
Determining the Macropinocytic Index
9:21
Results: Quantification of Macropinocytosis and Dose-Response Curve for Macropinocytosis Inhibitors
10:20
Conclusion
